Key facts
- It has raised $38.5M; the latest was Later Stage VC ($20.0M) in Sep 2024.
- Notable investors include Creative Destruction Lab, Perceptive Advisors, Next Ventures (Texas), Anges Québec, Aphelion Capital — 19 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 19 names
- ·Watchlist + deal alerts for Orpyx
- ·The full record, as it builds
Funding rounds
No funding rounds for Orpyx are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Orpyx
Developer of wearable sensor-based healthcare tools designed to prevent devastating complications to feet from peripheral neuropathy. The company's tools understand the daily pressure on the feet to avoid irreversible damage and manage peripheral neuropathy, enabling people to take control of their health, prevent debilitating complications, and extend their health span.
- Sector
- Healthcare
- HQ
- Calgary, Canada
- Founded
- 2010
- Employees
- 68
- Website
- orpyx.com/
- Ownership
- Privately Held (backing)
Orpyx doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Orpyx shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Orpyx in its N-PORT filings yet. We sweep new filings monthly.